IRADIMED CORP (IRMD) Stock Fundamental Analysis
NASDAQ:IRMD • US46266A1097
101 USD
+0.37 (+0.37%)
Last: Feb 18, 2026, 11:44 AM
Taking everything into account, IRMD scores 7 out of 10 in our fundamental rating. IRMD was compared to 185 industry peers in the Health Care Equipment & Supplies industry. IRMD gets an excellent profitability rating and is at the same time showing great financial health properties. IRMD is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes IRMD very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
- IRMD had positive earnings in the past year.
- In the past year IRMD had a positive cash flow from operations.
- IRMD had positive earnings in each of the past 5 years.
- Of the past 5 years IRMD 4 years had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 18.47%, IRMD belongs to the best of the industry, outperforming 99.46% of the companies in the same industry.
- The Return On Equity of IRMD (21.54%) is better than 95.14% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 19.32%, IRMD belongs to the top of the industry, outperforming 97.30% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for IRMD is significantly above the industry average of 8.75%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.47% | ||
| ROE | 21.54% | ||
| ROIC | 19.32% |
ROA(3y)19.63%
ROA(5y)17.03%
ROE(3y)23.33%
ROE(5y)20.07%
ROIC(3y)20.45%
ROIC(5y)17.53%
1.3 Margins
- IRMD has a Profit Margin of 26.31%. This is amongst the best in the industry. IRMD outperforms 96.76% of its industry peers.
- IRMD's Profit Margin has improved in the last couple of years.
- With an excellent Operating Margin value of 30.87%, IRMD belongs to the best of the industry, outperforming 98.38% of the companies in the same industry.
- In the last couple of years the Operating Margin of IRMD has grown nicely.
- Looking at the Gross Margin, with a value of 77.07%, IRMD belongs to the top of the industry, outperforming 89.73% of the companies in the same industry.
- In the last couple of years the Gross Margin of IRMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.87% | ||
| PM (TTM) | 26.31% | ||
| GM | 77.07% |
OM growth 3Y2.08%
OM growth 5YN/A
PM growth 3Y3.67%
PM growth 5Y44.08%
GM growth 3Y-0.3%
GM growth 5Y0.65%
2. Health
2.1 Basic Checks
- IRMD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- Compared to 1 year ago, IRMD has about the same amount of shares outstanding.
- IRMD has more shares outstanding than it did 5 years ago.
- IRMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- IRMD has an Altman-Z score of 49.89. This indicates that IRMD is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 49.89, IRMD belongs to the top of the industry, outperforming 98.92% of the companies in the same industry.
- IRMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 49.89 |
ROIC/WACC1.94
WACC9.98%
2.3 Liquidity
- A Current Ratio of 6.64 indicates that IRMD has no problem at all paying its short term obligations.
- IRMD has a better Current ratio (6.64) than 84.32% of its industry peers.
- A Quick Ratio of 5.72 indicates that IRMD has no problem at all paying its short term obligations.
- The Quick ratio of IRMD (5.72) is better than 84.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.64 | ||
| Quick Ratio | 5.72 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 16.36% over the past year.
- The Earnings Per Share has been growing by 36.18% on average over the past years. This is a very strong growth
- Looking at the last year, IRMD shows a quite strong growth in Revenue. The Revenue has grown by 14.43% in the last year.
- IRMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.45% yearly.
EPS 1Y (TTM)16.36%
EPS 3Y20.77%
EPS 5Y36.18%
EPS Q2Q%22.73%
Revenue 1Y (TTM)14.43%
Revenue growth 3Y16.29%
Revenue growth 5Y21.45%
Sales Q2Q%17.03%
3.2 Future
- Based on estimates for the next years, IRMD will show a small growth in Earnings Per Share. The EPS will grow by 5.87% on average per year.
- The Revenue is expected to grow by 10.59% on average over the next years. This is quite good.
EPS Next Y12.63%
EPS Next 2Y5.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.27%
Revenue Next 2Y10.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 52.60, the valuation of IRMD can be described as expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of IRMD indicates a somewhat cheap valuation: IRMD is cheaper than 68.65% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.16, IRMD is valued quite expensively.
- The Price/Forward Earnings ratio is 46.71, which means the current valuation is very expensive for IRMD.
- Based on the Price/Forward Earnings ratio, IRMD is valued a bit cheaper than the industry average as 67.57% of the companies are valued more expensively.
- IRMD's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.10.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 52.6 | ||
| Fwd PE | 46.71 |
4.2 Price Multiples
- IRMD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. IRMD is cheaper than 64.86% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of IRMD indicates a somewhat cheap valuation: IRMD is cheaper than 69.73% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 92.09 | ||
| EV/EBITDA | 47.36 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- IRMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.17
PEG (5Y)1.45
EPS Next 2Y5.87%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- IRMD has a yearly dividend return of 0.71%, which is pretty low.
- IRMD's Dividend Yield is rather good when compared to the industry average which is at 0.20. IRMD pays more dividend than 91.35% of the companies in the same industry.
- With a Dividend Yield of 0.71, IRMD pays less dividend than the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.71% |
5.2 History
- IRMD has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- IRMD pays out 39.59% of its income as dividend. This is a sustainable payout ratio.
DP39.59%
EPS Next 2Y5.87%
EPS Next 3YN/A
NASDAQ:IRMD (2/18/2026, 11:44:40 AM)
101
+0.37 (+0.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10 2026-02-10/bmo
Earnings (Next)05-04 2026-05-04
Inst Owners57.86%
Inst Owner Change5.61%
Ins Owners36.79%
Ins Owner Change-0.61%
Market Cap1.28B
Revenue(TTM)83.81M
Net Income(TTM)21.18M
Analysts82.5
Price Target100.98 (-0.02%)
Short Float %5.94%
Short Ratio6.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.71% |
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP39.59%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-23 2026-02-23 (0.2)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.85%
Min EPS beat(2)1.27%
Max EPS beat(2)10.44%
EPS beat(4)3
Avg EPS beat(4)2.54%
Min EPS beat(4)-1.96%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)4.28%
EPS beat(12)10
Avg EPS beat(12)6.04%
EPS beat(16)14
Avg EPS beat(16)9.77%
Revenue beat(2)2
Avg Revenue beat(2)0.71%
Min Revenue beat(2)0.01%
Max Revenue beat(2)1.41%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-1.05%
Max Revenue beat(4)1.41%
Revenue beat(8)3
Avg Revenue beat(8)-0.25%
Revenue beat(12)6
Avg Revenue beat(12)-0.02%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)0%
PT rev (3m)32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)2.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 52.6 | ||
| Fwd PE | 46.71 | ||
| P/S | 15.96 | ||
| P/FCF | 92.09 | ||
| P/OCF | 51.37 | ||
| P/B | 13.06 | ||
| P/tB | 13.53 | ||
| EV/EBITDA | 47.36 |
EPS(TTM)1.92
EY1.9%
EPS(NY)2.16
Fwd EY2.14%
FCF(TTM)1.1
FCFY1.09%
OCF(TTM)1.97
OCFY1.95%
SpS6.33
BVpS7.73
TBVpS7.47
PEG (NY)4.17
PEG (5Y)1.45
Graham Number18.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.47% | ||
| ROE | 21.54% | ||
| ROCE | 24.38% | ||
| ROIC | 19.32% | ||
| ROICexc | 43.38% | ||
| ROICexgc | 46.87% | ||
| OM | 30.87% | ||
| PM (TTM) | 26.31% | ||
| GM | 77.07% | ||
| FCFM | 17.33% |
ROA(3y)19.63%
ROA(5y)17.03%
ROE(3y)23.33%
ROE(5y)20.07%
ROIC(3y)20.45%
ROIC(5y)17.53%
ROICexc(3y)50.3%
ROICexc(5y)54.7%
ROICexgc(3y)53.86%
ROICexgc(5y)59.46%
ROCE(3y)25.8%
ROCE(5y)22.12%
ROICexgc growth 3Y-15.8%
ROICexgc growth 5YN/A
ROICexc growth 3Y-12.49%
ROICexc growth 5YN/A
OM growth 3Y2.08%
OM growth 5YN/A
PM growth 3Y3.67%
PM growth 5Y44.08%
GM growth 3Y-0.3%
GM growth 5Y0.65%
F-Score4
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 1128.47% | ||
| Cap/Sales | 13.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 96.82% | ||
| Profit Quality | 65.85% | ||
| Current Ratio | 6.64 | ||
| Quick Ratio | 5.72 | ||
| Altman-Z | 49.89 |
F-Score4
WACC9.98%
ROIC/WACC1.94
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.36%
EPS 3Y20.77%
EPS 5Y36.18%
EPS Q2Q%22.73%
EPS Next Y12.63%
EPS Next 2Y5.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.43%
Revenue growth 3Y16.29%
Revenue growth 5Y21.45%
Sales Q2Q%17.03%
Revenue Next Year11.27%
Revenue Next 2Y10.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.55%
EBIT growth 3Y18.71%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-18.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.2%
OCF growth 3YN/A
OCF growth 5YN/A
IRADIMED CORP / IRMD FAQ
Can you provide the ChartMill fundamental rating for IRADIMED CORP?
ChartMill assigns a fundamental rating of 7 / 10 to IRMD.
Can you provide the valuation status for IRADIMED CORP?
ChartMill assigns a valuation rating of 4 / 10 to IRADIMED CORP (IRMD). This can be considered as Fairly Valued.
Can you provide the profitability details for IRADIMED CORP?
IRADIMED CORP (IRMD) has a profitability rating of 9 / 10.
What are the PE and PB ratios of IRADIMED CORP (IRMD) stock?
The Price/Earnings (PE) ratio for IRADIMED CORP (IRMD) is 52.6 and the Price/Book (PB) ratio is 13.06.
Can you provide the financial health for IRMD stock?
The financial health rating of IRADIMED CORP (IRMD) is 9 / 10.